C4 Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Watertown, MA
CCCC chart
What traders are saying about $CCCC
Latest postsC4 Therapeutics, Inc. news
- C4 Therapeutics, Inc. (NASDAQ:CCCC) Just Reported And Analysts Have Been Lifting Their Price Targets
Simply Wall St ·
- C4 Therapeutics (CCCC) Stock Price, Chart & Analysis
debelegger.nl ·
- C4 Therapeutics Stock Price Forecast. Should You Buy CCCC?
StockInvest.us ·
- Guggenheim maintains C4 Therapeutics at Buy, lowers price target to $6 from $7
TradingView ·
- C4 Therapeutics, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- C4 Therapeutics Share News - Latest Updates, Live News & More
scanx.trade ·
- C4 Therapeutics Q3 Results: Loss narrows to $0.16, revenue falls 24.6%
scanx.trade ·
- C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Lags Revenue Estimates
Yahoo Finance ·
- C4 Therapeutics 3Q 2026: Revenue $8.47M, EPS ($0.16) — 10-Q Summary
TradingView ·
- C4 Therapeutics Reports Q3 2026 Results, $274.7 Million in Cash
TradingView ·
- C4 Therapeutics Q3 loss per share smaller than expected as R&D costs drop
TradingView ·
- Form 8K C4 Therapeutics Inc For: 5 November By Investing.com
Investing.com UK ·
C4 Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $35.9M | $35.6M | $20.8M | $31.1M |
| Net income | -$105.0M | -$105.3M | -$132.5M | -$128.2M |
| Diluted EPS | $-1.27 | $-1.52 | $-2.67 | $-2.62 |
| Total assets (year end) | $359.1M | $349.6M | $376.5M | $430.8M |
| Cash and equivalents (year end) | $74.6M | $55.5M | $126.6M | $29.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About C4 Therapeutics, Inc.
- Ticker
- CCCC (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Watertown, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1662579
Frequently asked questions
What exchange is C4 Therapeutics, Inc. listed on?
C4 Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CCCC.
What industry is C4 Therapeutics, Inc. in?
C4 Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is C4 Therapeutics, Inc. headquartered?
C4 Therapeutics, Inc.'s business address on file with the SEC is in Watertown, MA.
When does C4 Therapeutics, Inc.'s fiscal year end?
C4 Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did C4 Therapeutics, Inc. report?
C4 Therapeutics, Inc. reported $35.9M in revenue for calendar year 2025, according to its SEC filings.